drugset / Trial / NCT07710118

500-mg Versus 1000-mg Ceftriaxone for Uncomplicated Gonorrhea Infection

NCT07710118

RandomizedParallel-groupOpen-labelTreatment

Summary

This is a study to compare the treatment effect of different doses of ceftriaxone for gonorrhea.

Timeline

Start
2026-07
Primary completion
2028-12
Completion
2029-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Ceftriaxone Other / unclassified 500 mg Intramuscular
Subject Ceftriaxone Other / unclassified 1000 mg Intramuscular

Indications